John Oyler, a biotech CEO, reached a $1 billion net worth, earning himself a spot on the list.
Mr. Oyler is the CEO and co-founder of BeiGene, which was founded in Beijing in 2010. He owns 6 percent of the company.
Mr. Oyler also started and sold two companies before BeiGene, including telecom research firm Telephia and drug outsourcing company BioDuro, which he sold for $77 million in 2010.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.